Journal of Neuro-Oncology

Papers
(The H4-Index of Journal of Neuro-Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival57
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection50
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma40
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma39
Factors influencing timely diagnosis in neurolymphomatosis39
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence37
Prognostic factors among patients with brain metastases from cancer of unknown primary site37
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease36
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas35
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study35
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy34
MR susceptibility imaging for detection of tumor-associated macrophages inĀ glioblastoma33
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update33
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu32
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival30
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review30
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma30
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities29
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population29
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review28
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma28
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases27
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis27
Focused versus conventional radiotherapy in spinal oncology: is there any difference in fusion rates and pseudoarthrosis?27
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor26
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline26
A practical guide to neuro-oncology fellowship26
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review26
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management26
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis26
0.11056399345398